Singapore elected member of UN’s main drug policymaking body

Singapore has been elected for the term 2023-2026 to the United Nations Commission on Narcotic Drugs (CND).

The CND is the primary policymaking body of the United Nations in the field of drug control, charged with overseeing international drug control conventions and promoting cooperation in the struggle against drug trafficking and abuse.

Singapore’s election to the CND coincides with its intensified efforts to combat drug addiction and trafficking, with a strong emphasis on prevention, treatment, and rehabilitation.

Keep Reading

China rushes to produce COVID medications as Xi worries about rural outbreaks

Hong Kong outlaws cannabis derivative, forcing enterprises to close or change

Indonesia’s Oil and Gas Industry in Crisis: Is Nationalism to Blame?

The Central Narcotics Bureau of Singapore has collaborated closely with regional and international partners to share best practices and exchange intelligence on drug threats and trends.

It is anticipated that Singapore’s membership in the CND will strengthen its position as a regional leader in drug control and contribute to global efforts to combat drug misuse and trafficking.

The nation has pledged to collaborate with other CND members to develop drug policies and programs that prioritize public health, human rights, and social development.

The international community has welcomed Singapore’s election to the CND, with many expressing confidence in the nation’s ability to make significant contributions to the global struggle against drug abuse and trafficking.

In March 2023, the CND will conduct its first meeting of the 2023-2026 term in Vienna, where Singapore will be able to participate in the commission’s deliberations and decision-making processes.